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Abstract 
Recombinant expression systems for both ape(a) and apoB were used to identify sequences in apoB which are required for Lp(a) formation. 
Incubation of a [?S]Cys-labelled 17-kringle form of ape(a) with supernatants from rat hepatoma (McA-RH7777) cells expressing apoB-88, apoB-94 
and apoB-100 resulted in covalent r-Lp(a) formation only with apoB-100. Additionally, apoB-86 present in the LDL of a hypobetalipoproteinemic 
subject did not associate with a 12-kringle form of recombinant ape(a) to form r-Lp(a) complexes. Our data suggest hat sequences within the 
C-terminal 6% of apoB-100 are essential for Lp(a) assembly. 
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1. Introduction 
Numerous studies have identified lipoprotein(a) 
(Lp(a)) as an independent risk factor for the develop- 
ment of coronary heart disease [l]. Marked inherited 
variability has been observed with respect to plasma 
Lp(a) levels, which vary over lOOO-fold in the popula- 
tion. Roughly 25% of the human population possesses 
Lp(a) levels above 20 mg/dl, which more than doubles 
their risk of developing coronary heart disease. Lp(a) 
closely resembles a low density lipoprotein (LDL) parti- 
cle with respect o lipid composition and the presence of 
a single molecule of apolipoprotein B-100 (apoB-100). 
However, Lp(a) is distinguishable from LDL by the pres- 
ence of the protein moiety apolipoprotein(a) (ape(a)), 
which is covalently attached to apoB-100. Human ape(a) 
consists of multiple tandem repeats of a sequence that 
closely resembles plasminogen kringle IV, followed by 
sequences exhibiting a high degree of sequence similarity 
to the kringle V and protease regions of plasminogen [2]. 
Ape(a) is covalently linked to apoB-100 by a single disul- 
fide bond, involving Cys40s7 in the penultimate kringle IV 
repeat of ape(a) [3,4]. Fluorescence labelling studies [5,6] 
in addition to predictions based on computer modeling 
[6] suggest hat Cys3734 in apoB-100 participates in disul- 
fide bond formation with ape(a). In addition to covalent 
bond formation, there is evidence that strong hydropho- 
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Abbreviations: Lp(a), lipoprotein(a); apoB-100, apolipoproteinB-100; 
LDL, low density lipoprotein; r-ape(a), recombinant ape(a); r-Lp(a), 
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bit interactions between ape(a) and apoB-100 may also 
contribute to the formation of Lp(a) particles in vivo [7]. 
It has recently been demonstrated that Lp(a) particle 
assembly occurs extracellularly in human plasma [3]. As- 
sembly of Lp(a) in plasma has also been observed upon 
infusion of human LDL into transgenic mice expressing 
human ape(a) [8]. Extracellular assembly of Lp(a) also 
appears to occur in baboons based on studies in which 
Lp(a) could not be detected intracellularly in cultured 
baboon hepatocytes, but could be detected in culture 
supernatants [9]. However, the structural feature(s) 
which underlie the specific interaction of ape(a) and 
apoB- 100 to form Lp(a) particles remains to be deter- 
mined. 
Using an in vitro Lp(a) association assay, we now 
report that sequences in the carboxyl-terminal region, 
independent of CYS~‘~~, are required for Lp(a) particle 
assembly. 
2. Experimental 
2.1. Construction and expression of the 12-kringle form of ape(a) 
An ape(a) construct containing 12 kringle IV repeats was derived 
from partial IfhaI digestion of the 17-kringle recombinant ape(a) 
(r-ape(a)) construct pRKShal7 [IO]. A 385 bp EcoRI-HhaI fragment, 
containing 291 bp of the first kringle IV repeat of ape(a), was fused to 
a 4828 bp IfhaI-EcoRI fragment containing 51 bp of the 26th kringle 
repeat, followed by kringles 27-37 and the kringle V and protease 
domains [2]. The DNA fragments were ligated into pRKShal7 digested 
with EcoRI, and the resultant construct (pRKShal2) was verified by 
DNA sequence analysis. This construct was used to stably transfect 293 
(human embryonic kidney [I I]) cells as previously detailed for the 
293/apo(a).24 cell line [IO]. Briefly, cells were cultured in IOO-mm dishes 
using minimal essential medium (MEM) (Gibco/BRL) supplemented 
with 10% fetal calf serum (FCS) (ICN). Cells were transfected by the 
calcium-phosphate co-precipitation method [12] using 10 pg of 
pRKShal2 expression plasmid and 1 pug of a plasmid containing the 
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neomycin gene (pRSVneo [13]) per 100 mm dish. The selective agent 
G418 (800 /*g/ml of medium) (GibcolBRL) was added to the plates 48 
h post-transfection. Individual G418-resistant foci were subsequently 
transferred to 24-well dishes and positive clones were identified by 
immunoperoxidase staining using an affinity purified anti-ape(a) poly- 
clonal antibody raised in sheep. The isolate containing the greatest 
number of immunoreactive cells was subsequently cloned by limiting 
dilution; the resultant stable line was designated 293/apo(a).l2. 
Stably trdnsfected 293 cells expressing the 17-kringle r-ape(a) (293/ 
apo(a).24) or the l2-kringle form of r-ape(a) (293/apo(a).l2; see above) 
were routinely cultured in MEM supplemented with 10% FCS and 
G418 (400 ,@ml of media). The generation and characterization of 
McA-RH7777 cells stably transfected with plasmids expressing human 
apoB-100 as well as carboxyl-terminal truncations of apoB (apoB-88 
and apoB-94) has been previously described [14]. ApoB-88 contains the 
amino-terminal 4,002 amino acids of apoB-100 whereas apoB-94 con- 
tains the amino-terminal 4,270 amino acids of apoB-100. These cell 
lines were routinely cultured in MEM supplemented with 20% FCS and 
400 ,@ml G418. 
2.2. Analysis of recombinant apoB (r-apoB) expression levels 
Wild-type McA-RH7777 cells (ATCC# CRL 1601) or those stably 
expressing C-terminal apoB variants were grown to confluence and 
incubated for 24 h in serum-free MEM. Cell culture supernatants were 
harvested, clarified by brief centrifugation at 181 Sxg and concentrated 
in Centricon microconcentrators (100 kDa size exclusion; Amicon). 
Concentrated media or purified LDL (see below) was added to 
Laemmli sample buffer, boiled for 5 min, and subjected to SDS-PAGE 
using a 5% gel [15]. The gel was blotted onto nitrocellulose (Bio-Rad) 
overnight at 40 V in 25 mM Tris-HCl, 192 mM glycine containing 20% 
methanol. Immunoblots were incubated in blocking buffer (1 GNET 
(1.5 M NaCI. 50 mM EDTA. 0.5 M Tris-HCI. 0.5% Triton X-100) 
containing 3% BSA), followed by incubation with the apoB-specific 
monoclonal antibody ID1 [16] in I xNET buffer (1Dl was a gift from 
Drs. R.W. Mime and Y.L. Marcel, Lipoprotein and Atherosclerosis 
Group, University of Ottawa Heart Institute, Ottawa). Specific im- 
munoreactive complexes were detected using enhanced chemilumines- 
cence as detailed by the manufacturer (Amersham). 
2.3. Metabolic labelling of’cells 
293/apo(a).24 or 293/ape(a). I2 cell lines were incubated for 45 min 
in Met/Cys-depleted MEM (Gibco/BRL), supplemented with 2 mM 
elutamine. in the absence of FCS. I”SlCvs (ICN) was then added (5 
,&ml of media) and cell super&a&-were harvested 3.5 h post- 
labelling. Supernatants were clarified by brief centrifugation at 1815 x g 
for use in in vitro association studies (see below). 
2.4. Assay,for recombinanl Lp(a) particle formation 
Concentrated supernatants from either wild-type McA-RH7777 cells 
or those expressing various apoB species were incubated with [“S]Cys- 
labelled media harvested from the 293/apo(a).24 cell line at 37“C for 
1 h. Control samples consisted of either an equal volume of PBS or 
purified human LDL (see below) equivalent to the amount of r-apoB- 
100 detected by Western blot analysis. At the end of the incubation 
period, samples were immunoprecipitated overnight at 4°C with IO-20 
pg of a monoclonal antibody directed against ape(a) 1171. Samples were 
then incubated with protein A-Sepharose (Pharmacia LKB Biotechnol- 
ogy Inc.) for 1 h, after which the Sepharose was pelleted by brief 
centrifugation at 16,000 x g, washed with RIPA buffer [IO] and resus- 
pended in Laemmli sample buffer; dithiothreitol (DTT) was added to 
a final concentration of IO mM in order to reduce samples where 
required. Samples were boiled for 5 min and proteins were resolved by 
SDS-PAGE using either a 5% gel or a 2.5-l 5% gradient gel. Gels were 
then treated with Enlightning (DuPont) for 15 min, dried under vacuum 
and exposed to film at -70°C with intensifying screens. 
Human plasma from either a normolipidemic control individual or 
a human subject with hypobetalipoproteinemia (H.J.B. [18]; reviewed 
in [19]) was subjected to ultracentrifugation at 436,000 xg for 2 h at 
15°C. The top one-tenth representing the d < 1.006 g/ml fraction was 
discarded and the density of the infranatant was adjusted to 1.063 g/ml 
with NaBr and centrifuged using the conditions described above. The 
top one-tenth of each tube representing the LDL fraction was harvested 
and the protein levels determined using a Bradford assay (Bio-Rad). 
Purified LDL isolated from acontrol individual (0.3pg) or from H.J.B. 
(3 pg) was incubated with [“S]Cys-1abelled media (950 ~1) harvested 
from the 293/apo(a).12 cell line for 2 h at 37°C. Samples were im- 
munoprecipitated at 4°C overnight with 2Opg of a polyclonal antibody 
raised against human LDL (Boehringer-Mannheim) and analyzed by 
SDS-PAGE and fluorography as described above. 
3. Results and discussion 
Using an in vitro association assay [3], we have studied 
the effect of carboxyl-terminal deletions of apoB on the 
ability of apoB to associate with recombinant ape(a) 
(r-ape(a); [lo]) to form Lp(a) particles (r-Lp(a)). We ini- 
tially assessed the ability of full-length recombinant 
apoB-100 (r-apoB-100) to form covalent r-Lp(a) com- 
plexes with r-ape(a). In this experiment, equivalent 
amounts of either purified human LDL or r-apoB-100 
(present in the cell culture supernatants harvested from 
the McA-RH7777 B-100 stable line) were incubated with 
[“S]Cys-1abelled r-ape(a); mixtures were immunoprecip- 
itated using an ape(a)-specific monoclonal antibody, and 
analyzed by SDS-PAGE. The resulting fluorogram is 
shown in Fig. IA. Similar amounts of a disulfide-linked 
species corresponding to r-Lp(a) (which disappears upon 
sample reduction) was observed when either purified 
LDL or conditioned media from the McA-RH7777 
B-100 cell line were used in the assay. Furthermore, the 
formation of r-Lp(a) increased (relative to free ape(a)) 
upon addition of increased amounts of r-apoB-100 (Fig. 
lB), as has been previously demonstrated for LDL [3]. 
The r-Lp(a) formed was specific for human r-apoB-100 
as no r-Lp(a) was observed in control samples containing 
conditioned media from wild-type McA-RH7777 cells, 
although these cells express rat apoB-48 and apoB-100 
[20]. A non-specific band is, however, frequently ob- 
served under non-reducing conditions (Fig. 1A); this 
band corresponds to a dimerized form of r-ape(a), which 
cannot be immunoprecipitated with antibodies directed 
against LDL. The results shown in Fig. 1A and B dem- 
onstrate that the r-apoB expression system could be util- 
ized to analyze the effect of carboxyl-terminal trunca- 
tions of apoB-100 on r-Lp(a) formation, and that the 
interpretation of these studies would not be affected by 
the presence of rat apoB. It is noteworthy that the ab- 
sence of covalent association of rat apoB-100 with 
r-ape(a) is consistent with previous data obtained from 
a study of transgenic mice expressing human ape(a); in 
that study, covalent association of ape(a) with murine 
LDL was not observed [S]. Taken together with our data, 
these observations indicate that rat and murine apoB- 
100 have distinct structural features which preclude co- 
valent association with human ape(a). 
We have also used the McA-RH7777 apoB expression 
system [14] to examine the effect of carboxyl-terminal 
truncation of human apoB on r-Lp(a) formation. Condi- 
tioned media collected from wild-type McA-RI-I7777 
cells or those cells stably expressing human apoB-88, 
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Fig. 1. In vitro formation of r-Lp(a) employing r-apoB-100 and human 
LDL. (A) The organization of the recombinant proteins corresponding 
to apoB-100, apoB-94 and apoB-88 are shown. Positions and amino 
acid numbers of the last four cysteines in apoB-100 are indicated; 
Cys”” and Cys4190 are exposed on the LDL surface as demonstrated 
by fluorescent labelling studies [6]. (B) Purified human LDL (1.5 pg) 
or cell culture supernatants (50~1) from either wild-type McA-RH7777 
cells or the stable cell line McA-RH7777 B-100 were incubated with 
[‘5S]Cys-labelled media (950 ~1) harvested from the 293/apo(a).24 cell 
line for I h at 37°C. Samples were imunoprecipitated with an apo(a)- 
specific monoclonal antibody and analyzed by SDS-PAGE using a 5% 
gel. The gel was treated with Enlightning, dried and exposed to film. 
The positions of free r-ape(a) and the r-Lp(a) complex are indicated. 
Non-reduced (NR) samples were resuspended in Laemmli sample 
buffer while reduced samples (R) were resuspended in the same volume 
of sample buffer containing IO mM DTT; samples were boiled for 5 min 
prior to loading. (C) [35S]Cys-labelled media (950.~1) harvested from the 
293/apo(a).24 cell line was incubated with increasing volumes of media 
harvested from the McA-RH7777 B-100 cell line for I h at 37°C. 
Samples were treated as detailed above with the exception that they 
were resolved on a 2.5515% gradient gel. The positions of free r-ape(a) 
(F) and the r-Lp(a) particle (P) are indicated to the right of the gel. 
apoB-94, or apoB-100 (Fig. 2A) was analyzed for the 
production of truncated apoBs by Western blot analysis 
(Fig. 2B); similar amounts of all of the recombinant 
79 
apoB species were detected. For in vitro association stud- 
ies (Fig. 2C), samples of the supernatants (equivalent o 
- 1.5pg ofeach truncated apoB, and - 10 times the amount 
of apoB used in the Western blot experiment shown in 
Fig. 2B) was added to [35S]Cys-labelled supernatants 
from the 293/apo(a).24 cell line. Although both LDL and 
r-apoB-100 formed significant amounts of covalent r- 
Lp(a) complexes, no r-Lp(a) was observed when r-ape(a) 
was incubated with conditioned media from the McA- 
RH7777 B-94 or McA-RH7777 B-88 cell lines. Reduced 
levels of expression of r-apoB-88 or r-apoB-94 could not 
account for this result as virtually identical amounts of 
the recombinant apoB species and purified LDL were 
used in these assays, based on the data presented in Fig. 
2B. It could be suggested that the presence of r-apoB-48 
observed in the different apoB cell lines may have inhib- 
ited r-Lp(a) formation. However, this does not appear to 
be the case since similar amounts of r-Lp(a) were ob- 
served using both the purified LDL and r-apoB-100, 
despite the considerable amount of apoB-48 present in 
the supernatants from the McA-RH7777 cells (Fig. 2B). 
Furthermore, less apoB-48 was observed in the condi- 
tioned media isolated from the McA-RH7777 B-94 cell 
line compared to the McA-RH7777-B-100 cell line (Fig. 
2B). Thus, neither the expression levels of the carboxyl- 
terminal truncated apoB species, nor the variable pres- 
ence of apoB-48, could explain the absence of r-Lp(a) 
formation. 
We have previously demonstrated that r-Lp(a) forma- 
tion is a time-dependent reaction that is virtually com- 
plete within 90 min [3]. It is conceivable that carboxyl- 
terminal truncations of apoB could alter the kinetics of 
r-Lp(a) formation. To address this possibility, either pu- 
rified LDL, or conditioned media from the McA- 
RH7777 B-94 and McA-RH7777 B-100 cell lines, were 
incubated with [3SS]Cys-labelled r-ape(a) for 4 h. Similar 
amounts of r-Lp(a) could be observed with LDL and 
r-apoB-100, but no r-Lp(a) was observed with r-apoB- 
94; over-exposure of this gel still did not allow detection 
of any r-Lp(a) containing r-apoB-94 (data not shown). 
To verify the data obtained using the apoB expression 
system, we analyzed r-Lp(a) formation using LDL puri- 
fied from the plasma of a hypobetalipoproteinemic sub- 
ject, H.J.B. [18]. H.J.B. is a compound heterozygote for 
hypobetalipoproteinemia, and his plasma lipoproteins 
contain apoB-100, apoB-86 (containing the same cyste- 
ine residues as apoB-88; see Fig. 2A), apoB-48, and 
apoB-37 ([19] and references therein). We incubated 
LDL purified from a control individual and from H.J.B. 
with [35S]Cys-labelled media harvested from the 2931 
apo(a).l2 cell line, and immunoprecipitated the Lp(a) 
complexes with a polyclonal antibody specific for human 
LDL; the results are shown in Fig. 3. r-Lp(a) was ob- 
served when purified LDL from either individual was 
used; however, the r-Lp(a) corresponded in size to that 
consisting of only the full-length apoB-100. The 293/ 
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Fig. 2. C-Terminal truncation of apoB-100 eliminates r-Lp(a) forma- 
tion. (A) Expression levels of cell culture supernatants from McA- 
RH7777 cells stably transfected with apoB-100, apoB-94 and apoB-88 
[I41 were analyzed by SDS-PAGE (5% gel) followed by Western blot- 
ting. The blot was probed with the 1 Dl monoclonal antibody specific 
for the amino terminal region of apoB-100. The apoB plasmids used 
to generate the stable rat hepatoma cell lines are indicated above each 
lane. Conditioned media from wild-type McA-RH7777 cells as well as 
purified human LDL (150 ng) were included as controls. The positions 
of the truncated recombinant apoB proteins are indicated to the left of 
the blot. (B) [‘S]Cys-labelled media (1 ml) from the 293/apo(a).24 cell 
line was incubated for 1 h at 37°C with purified LDL (1.5 pg) or with 
supernatants harvested from the apoB-expressing cell lines correspond- 
ing to 10 times the volume used for the Western blot analysis in A. 
Samples were immunoprecipitated with an anti-ape(a) monoclonal an- 
tibody and resolved by SDS-PAGE using a 5% gel. The gel was treated 
with Enhghtning, dried under vacuum and exposed to film. The posi- 
tions of free r-ape(a) and r-Lp(a) complexes are indicated to the left of 
the fluorogram; the apoB plasmids used to generate the cell lines are 
indicated above each lane. 
apo. 12 cell line was utilized for this study since its smaller 
size would easily allow for the discrimination of r-Lp(a) 
particles containing either apoB-100 or r-Lp(a) particles 
containing apoB-86. The results of this experiment sup- 
port those obtained using the recombinant apoB expres- 
sion system, and confirm that carboxyl-terminal trunca- 
tions of apoB render it incapable of forming a covalent 
complex with ape(a). These results are also in agreement 
with earlier studies in which carboxyl-terminal apoB 
truncations could not be detected in the Lp(a) from hy- 
pobetalipoproteinemic subjects [19]. However, in those 
studies, alternative explanations such as accelerated 
clearance of Lp(a) particles containing truncated apoB 
species could not be ruled out [ 191. Our studies, which 
used in vitro association methodologies, are not subject 
to these criticisms and strongly indicate that carboxyl- 
terminal truncation of apoB is not compatible with 
r-Lp(a) formation. 
The results that we have obtained in this study, indi- 
cating that apoB species as long as apoB-94 cannot form 
r-Lp(a), are unexpected since previous work has impli- 
cated the involvement of apoB Cys3734 [5,6] in disulfide 
bridge formation with ape(a) Cys405’ [3,4]. CYS”‘~ of 
apoB is present in both r-apoB-88 and r-apoB-94, as well 
as in apoB-86 from H.J.B.‘s LDL, yet these truncated 
apoB species are incapable of forming a covalent com- 
plex with r-ape(a). A number of possible interpretations 
of these findings can be considered. The simplest inter- 
pretation is that CYS~~*‘~, which is absent from all of the 
truncated apoB species that we have investigated (see 
Fig. 2A), is the cysteine involved in disulfide bond forma- 
tion with CASKS” . m ape(a). However, the work of Cole- 
man et al. [5] and Guevara et al. [6] seems to preclude this 
possibility since Cys4326 appears to be inaccessible for 
association with ape(a), although the evidence presented 
to date has been indirect. Site-directed mutagenesis of the 
carboxyl-terminal cysteine residues of apoB-100 will be 
necessary for the unequivocal identification of the cyste- 
ine residue(s) that is involved in the covalent linkage to 
ape(a). 
It remains possible that Cys3734 within apoB partici- 
r_@(a) - 
Fig. 3. r-Lp(a) formation employing LDL from a subject with hy- 
pobetalipoproteinemia (H.J.B.). [3sS]Cys-labelled media (950 ~1) from 
cells stably transfected with pRK5ha12 were incubated for 2 h at 37°C 
with LDL isolated from a control individual (CON/LDL) or 3 pg of 
LDL isolated from an individual expressing apoB-100, apoB-86, apoB- 
48 and apoB-37 (HJBILDL). Samples were immunoprecipitated with 
a polyclonal antibody against human LDL and the products were 
analyzed by SDS-PAGE (5% gel) and fluorography as previously de- 
scribed. The position of r-Lp(a), corresponding to a particle containing 
apoB-100, is indicated. 
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pates in covalent linkage with ape(a), but that other 
factors prevent truncated apoBs containing Cys3734 from 
forming Lp(a) complexes. Carboxyl-terminal truncation 
of apoB- 100 impairs lipid recruitment by apoB [ 141. This 
reduction in lipid associated with the carboxyl-terminal 
truncated apoB species, such as apoB-94, may affect 
their ability to associate with ape(a). Indeed, immuno- 
chemical studies with monoclonal antibodies have dem- 
onstrated that alterations in core lipid content can affect 
the surface conformation of apoB ([21] and references 
therein). Moreover, it is possible that deletion of the 
carboxyl-terminal 6% of apoB results in the removal of 
sequences which are necessary for mediating the associa- 
tion of apoB and ape(a). Interestingly, no non-covalent 
association of ape(a) with either apoB-86, apoB-88 or 
apoB-94 was observed (data not shown). Therefore, se- 
quences within the C-terminal 6% of apoB may be re- 
quired for the initial non-covalent association of apoB 
with ape(a) but would not preclude the involvement of 
a more remote cysteine residue such as Cys3734 in disul- 
fide bond formation. 
This study represents the first report that sequences 
present within the carboxyl-terminal6% of apoB- 100 are 
required for its covalent association with ape(a) to form 
Lp(a) particles. This region may contain sequences re- 
quired for covalent or non-covalent interactions with 
ape(a), or perhaps both. Utilization of the recombinant 
expression systems for both ape(a) and apoB will be 
useful in further characterizing the nature of these se- 
quence requirements. This knowledge will be essential to 
our understanding of the mechanism of Lp(a) particle 
assembly. 
Acknowledgements: The authors wish to thank Drs. R.W. Mime and 
Y.L. Marcel for providing monoclonal anti-apoB antibody ID]. This 
work was supported by the Medical Research Council of Canada 
(M.L.K. and Z.Y.); Z.Y. is a research scholar of the Alberta Heritage 
Foundation for Medical Research. 
81 
References 
[I] Scanu, A.M. (1992) J. Internal Med. 231, 6799683. 
[2] McLean, J.W., Tomlinson, J.E., Kuang, W., Eaton, D.L., Chen, 
E., Fless, G., Scanu, A. and Lawn, R.M. (1987) Nature 330, l32- 
137. 
[3] Koschinsky, M.L., Cot.& G.P., Gabel, B. and van der Hoek, Y.Y. 
(1993) J. Biol. Chem. 268, 19819-19825. 
[4] Brunner, C., Kraft, H.-G., Utermann, G. and Muller, H.-J. (1993) 
Proc. Nat]. Acad. Sci. USA 90, 11643-l 1647. 
[S] Coleman, R.D., Kim, T.W., Gotto Jr., A.M. and Yang, C.-Y. 
(1990) Biochim. Biophys. Acta 1037, 129-132. 
[6] Guevara, J., Jr., Spurlino, J., Jan, A.Y., Yang, C.-Y., Tulinsky, A., 
Venkataram Prasad, B.V., Gaubatz, J.W. and Morrisett, J.D. 
















Trieu, V.N. and McConathy, W.J. (1990) Biochemistry 29, 5919- 
5924. 
Chiesa, G., Hobbs, H.H., Koschinsky, M.L., Lawn, R.M., Maika, 
SD. and Hammer, R.E. (1992) J. Biol. Chem. 267,24369-24374. 
White, A.L., Rainwater, D.L. and Lanford, R.E. (1993) J. Lipid 
Res. 34, 5099517. 
Koschinsky, M.L., Tomlinson, J.E., Zioncheck, T.J., Schwartz, 
K., Eaton, D.L. and Lawn, R.M. (1991) Biochemistry 30, 5044 
5051. 
Graham, F.L., Smiley, J., Russell, W.C. and Naim, R. (1977) 
J. Gen. Virol. 36, 59-77. 
Graham, F.L. and van der Eb, A.J. (1973) Virology 52, 456467. 
Gorman, C., Padmanahban, R. and Howard, B. (1983) Science 
221, 551-553. 
McLeod, R.S., Zhao, Y., Selby, S.L., Westerlund, J. and Yao, Z. 
(1994) J. Biol. Chem. 269, 2852-2862. 
Laemmli, U.K. (1970) Nature 227, 68&685. 
Pease, R.J., Milne, R.W., Jessup, W.K., Law, A., Provost, P., 
Fruchart, J.-C., Dean, R.T., Marcel, Y.L. and Scott, J. (1990) 
J. Biol. Chem. 265, 553-568. 
Wong, W.L.T., Eaton, D.L., Berloui, A., Fendly, B. and Hass, 
P.E. (1990) Clin. Chem. 36, 192-197. 
Steinberg, D., Grundy, SM., Mok, H.Y.I., Turner, J.D., Wein- 
stein, D.B., Brown, W.V. and Albers, J.J. (1979) J. Clin. Invest. 
64, 292-301. 
Linton, M.F., Farese Jr., R.V. and Young, S.G. (1993) J. Lipid 
Res. 34, 521-541. 
Tanabe, S., Sherman, H., Smith, L., Yang, L.-A., Fleming, R. and 
Hay, R. (1989) In Vitro 25, 1129-l 140. 
Chan, L. (1992) J. Biol. Chem. 267, 25621-25624. 
